Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy
NCT07664956
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Typical postoperative pain control after minimally invasive hysterectomy includes ibuprofen, acetaminophen, and a short course of narcotics. The purpose of this study is to see if adding cyclobenzaprine to this regime improves pain control and lessens narcotic use.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Minimally Invasive Surgical Procedures
- Abnormal Uterine Bleeding, Unspecified
- Adenomyosis of Uterus
- Fibroid Uterus
- Chronic Pelvic Pain
- Endometriosis
- Menorrhagia
- Endometritis
- Adnexal Diseases
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- 18 years and older
- Sex
- Female
- Healthy volunteers
- Not accepted
- Sponsor
- Christiana Care Health Services
- Last updated on ClinicalTrials.gov
- November 20, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Delaware · 1
- ChristianaCare Health System · Newark, DE
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.